Jaber H. Jaradat, MD
Curriculum Vitae • Jaber Husam Jaradat, M.D.
Full Bibliography (40+)

JABER HUSAM JARADAT, M.D.

Medical Intern | Physician–Scientist | Founder of BrighterUs | AACR GSITA Awardee

Amman, Jordan • +962-7806-78893 • jaberjaradat2002@gmail.com

Professional Profile

Medical doctor and current intern (Mutah University, Class of 2026; Al-Bashir Hospital) pursuing U.S. Internal Medicine residency training, with comprehensive experience across inpatient and outpatient care and an academic focus in translational oncology. Author/co-author of 40+ peer-reviewed scholarly outputs and recipient of the 2026 AACR Global Scholar-in-Training Award. Research expertise spans multi-omics bioinformatics, machine learning, evidence synthesis, and immunohistochemistry. Founder of BrighterUs, a patient-centered digital cancer support platform. Career goal: Internal Medicine and oncology at the intersection of clinical care, precision medicine, and computational research.

Education & Examinations

Doctor of Medicine (M.D.) 09/2020 – 06/2026

Faculty of Medicine, Mutah University — Al-Karak, Jordan

USMLE Step 1: Scheduled for December 2026
USMLE Step 2 CK: Planned for May/June 2027

Clinical Experience

Medical Intern — Al-Bashir Hospital 07/2026 – Present
Amman, Jordan
  • Provide supervised inpatient and outpatient care across medical and surgical services, including daily clinical assessment, evidence-based management, and documentation.
  • Participate in ward rounds, emergency acute evaluations, intensive diagnostic workups, and multidisciplinary tumor boards and care conferences.
  • Perform and assist with core clinical procedures including arterial blood gas sampling, IV line placement, venipuncture, urinary catheterization, wound management, and suturing.
Clinical Clerkships — Faculty of Medicine, Mutah University 2023 – 2026
Al-Karak, Jordan
  • Completed comprehensive core clinical rotations across Internal Medicine, General Surgery, Pediatrics, Obstetrics & Gynecology, Psychiatry, Family Medicine, and Emergency Medicine.
  • Actively participated in inpatient and outpatient diagnostic evaluations, bedside rounds, structured case presentations, and supervised clinical therapeutic planning.
Clinical Elective Rotations — Zarqa Governmental Hospital 07/2025 – 09/2025
Zarqa, Jordan
  • Completed focused clinical electives in Internal Medicine and General Surgery with direct engagement in inpatient hospital rounds, outpatient clinics, and pre-/post-operative care.

Research Experience & Collaborations

Cancer Bioinformatics Researcher & Lead Author 2024 – Present
Translational Oncology Collaborations (Remote / International) • UPMC Hillman Cancer Center & OU Stephenson Cancer Center
  • Collaborate with translational oncology teams (e.g., Dr. Anwaar Saeed’s group at UPMC Hillman Cancer Center and Dr. Abdul Rafeh Naqash’s team at OU Stephenson Cancer Center) on high-dimensional multi-omics, biomarker discovery, and immuno-oncology projects.
  • Develop machine learning and survival regression models for prognostic biomarker identification and clinical outcome risk stratification.
  • Analyze bulk RNA-seq, single-cell RNA-seq (scRNA-seq), scATAC-seq, and spatial transcriptomics datasets using reproducible R and Python workflows.
  • Design and validate tumor-microenvironment and inflammation-associated gene expression signatures across solid neoplasms (NSCLC, HCC, Sarcomas, Bladder).
  • Contribute to wet-lab validation via immunohistochemistry (IHC), tissue processing, slide staining optimization, and digital pathology quantification with QuPath.
  • Lead and author systematic reviews and Bayesian network meta-analyses evaluating novel oncologic treatments aligned with PRISMA guidelines.

Honors & Awards

  • Global Scholar-in-Training Award (GSITA), American Association for Cancer Research (AACR), 2026
  • Mutah University Junior Researcher Award for Excellence, Mutah University Faculty of Medicine, 2025–2026

Conference Presentations

  • AACR Annual Meeting 2026, San Diego, USA — Integrated bulk and single-cell transcriptomics reveal PARL as a mitochondrial regulator associated with immunometabolic reprogramming in NSCLC (Poster)
  • ASCO GI Cancers Symposium 2025, San Francisco, USA — Prognostic immune cell landscape in HCC progression (Poster)
  • American Academy of Neurology (AAN) Annual Meeting 2025, San Diego, USA — CNS Lymphoma meta-analysis (Poster)
  • Mutah University Faculty of Medicine Conferences (1st & 2nd), Al-Karak, Jordan (Oral & Poster)
  • 5th International Medical Conference of Al-Karak, Jordan (Oral presentation)

Technical & Experimental Skills

Programming & Data Science: Python, R, Linux/Bash, Git/GitHub, SPSS, Jamovi, HTML/CSS/JavaScript.
Bioinformatics & Genomics: Bulk RNA-seq, scRNA-seq, scATAC-seq, spatial transcriptomics, multi-omics integration, FastQC, MultiQC, Trimmomatic, Samtools, BLAST, molecular docking.
Machine Learning & AI: PyTorch, deep learning, ensemble methods, gradient boosting (XGBoost), medical imaging pipelines.
Evidence Synthesis: PRISMA-compliant systematic reviews, frequentist & Bayesian network meta-analysis, GRADE, risk-of-bias evaluation, RevMan 5, OpenMeta.
Wet Lab / Digital Pathology: Immunohistochemistry (IHC), tissue processing, staining optimization, microscopy, QuPath digital image quantification.

Selected Peer-Reviewed Bibliography (40+ Scholarly Outputs)

View full bibliography →
  1. Al-zu'bi B, Jaradat JH, et al. Glypican-1 in rhabdomyosarcoma: a multi-omics exploration of a targetable biomarker. Current Cancer Drug Targets. 2026.
  2. Bahr A, Jaradat JH, et al. Trispecific antibodies: from challenges to integration in cancer therapy. Critical Reviews in Oncology/Hematology. 2026.
  3. Jaradat JH, et al. Efficacy and safety of ibrutinib in CNS lymphoma: a meta-analysis. Critical Reviews in Oncology/Hematology. 2024.
  4. Jaradat JH, et al. HOOK3 amplification as a biomarker in bladder cancer. Anticancer Research. 2025.
  5. Al-zu'bi B, Jaradat JH, et al. Expression and clinical significance of cytochrome 1B1 in bone sarcomas. Pharmaceuticals. 2025.
  6. Alomari L, Jaradat JH, et al. A clustering-based machine learning approach for mortality prediction in gastrointestinal bleeding: development and validation. Gastro Hep Advances. 2026.
  7. Al-Sarireh YM, Jaradat JH, et al. Characterization of CYP4B1 expression in breast carcinoma through immunohistochemistry and in silico modeling. Breast Cancer: Targets and Therapy. 2026.
  8. Jaradat JH, et al. The multifaceted role of STRIP2 in disease pathogenesis and cancer progression. Anticancer Research. 2024.
  9. Jaradat JH, et al. The multifaceted role of AASDH: from metabolic regulation to cancer and cardiomyopathies. Anticancer Research. 2025.
  10. Eldeeb HA, Jaradat JH, et al. Comparative analysis of transradial vs. transfemoral approaches in radioembolization for liver tumors: a meta-analysis. Cardiovascular and Interventional Radiology. 2024.
  11. Jaradat JH, et al. Goalie phenomenon: unveiling hidden health conditions in young athletes. Health Care Science. 2025.
  12. Nasser A, Jaradat JH, et al. Endoscopic retrograde cholangiopancreatography for non-surgical bronchobiliary fistula resolution after hydatid cyst resection. İstanbul Tıp Fakültesi Dergisi. 2026.
  13. Seraj I, Jaradat JH, et al. Vaccines for Alzheimer's disease: a brief scoping review. Neurological Sciences. 2025.
  14. Al Shabilat SA, Jaradat JH, et al. COVID-19 severity and lab abnormalities in G6PD-deficient patients: meta-analysis. Oman Medical Journal. 2026.
  15. Nashwan AJ, Jaradat JH, et al. Iron overload in CKD patients on peritoneal dialysis: a scoping review. Health Science Reports. 2024.

Selected References

Anwaar Saeed, M.D., Ph.D.
Associate Professor of Medicine; Chief, Gastrointestinal Medical Oncology; Director, GI Disease Center
UPMC Hillman Cancer Center
Yousef M. Al-Sarireh, Ph.D.
Associate Professor
Department of Pharmacology, Faculty of Medicine, Mutah University — Al-Karak, Jordan
Walid Alwadi, M.D.
Consultant Internist
Department of Internal Medicine, Al-Karak Governorate Hospital / Faculty of Medicine, Mutah University